Cargando…

Reliability of Addenbrooke's Cognitive Examination III in differentiating between dementia, mild cognitive impairment and older adults who have not reported cognitive problems

Diagnosing dementia can be challenging for clinicians, given the array of factors that contribute to changes in cognitive function. The Addenbrooke’s Cognitive Examination III (ACE-III) is commonly used in dementia assessments, covering the domains of attention, memory, fluency, visuospatial and lan...

Descripción completa

Detalles Bibliográficos
Autores principales: Potts, C., Richardson, J., Bond, R. B., Price, R. K., Mulvenna, M. D., Zvolsky, P., Harvey, M., Hughes, C. F., Duffy, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456688/
https://www.ncbi.nlm.nih.gov/pubmed/34566550
http://dx.doi.org/10.1007/s10433-021-00652-4
_version_ 1784570919819149312
author Potts, C.
Richardson, J.
Bond, R. B.
Price, R. K.
Mulvenna, M. D.
Zvolsky, P.
Harvey, M.
Hughes, C. F.
Duffy, F.
author_facet Potts, C.
Richardson, J.
Bond, R. B.
Price, R. K.
Mulvenna, M. D.
Zvolsky, P.
Harvey, M.
Hughes, C. F.
Duffy, F.
author_sort Potts, C.
collection PubMed
description Diagnosing dementia can be challenging for clinicians, given the array of factors that contribute to changes in cognitive function. The Addenbrooke’s Cognitive Examination III (ACE-III) is commonly used in dementia assessments, covering the domains of attention, memory, fluency, visuospatial and language. This study aims to (1) assess the reliability of ACE-III to differentiate between dementia, mild cognitive impairment (MCI) and controls and (2) establish whether the ACE-III is useful for diagnosing dementia subtypes. Client records from the Northern Health and Social Care Trust (NHSCT) Memory Service (n = 2,331, 2013–2019) were used in the analysis including people diagnosed with Alzheimer’s disease (n = 637), vascular dementia (n = 252), mixed dementia (n = 490), MCI (n = 920) and controls (n = 32). There were significant differences in total ACE-III and subdomain scores between people with dementia, MCI and controls (p < 0.05 for all), with little overlap between distribution of total ACE-III scores (< 39%) between groups. The distribution of total ACE-III and subdomain scores across all dementias were similar. There were significant differences in scores for attention, memory and fluency between Alzheimer’s disease and mixed dementia, and for visuospatial and language between Alzheimer’s disease–vascular dementia (p < 0.05 for all). However, despite the significant differences across these subdomains, there was a high degree of overlap between these scores (> 73%) and thus the differences are not clinically relevant. The results suggest that ACE-III is a useful tool for discriminating between dementia, MCI and controls, but it is not reliable for discriminating between dementia subtypes. Nonetheless, the ACE-III is still a reliable tool for clinicians that can assist in making a dementia diagnosis in combination with other factors at assessment.
format Online
Article
Text
id pubmed-8456688
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-84566882021-09-22 Reliability of Addenbrooke's Cognitive Examination III in differentiating between dementia, mild cognitive impairment and older adults who have not reported cognitive problems Potts, C. Richardson, J. Bond, R. B. Price, R. K. Mulvenna, M. D. Zvolsky, P. Harvey, M. Hughes, C. F. Duffy, F. Eur J Ageing Original Investigation Diagnosing dementia can be challenging for clinicians, given the array of factors that contribute to changes in cognitive function. The Addenbrooke’s Cognitive Examination III (ACE-III) is commonly used in dementia assessments, covering the domains of attention, memory, fluency, visuospatial and language. This study aims to (1) assess the reliability of ACE-III to differentiate between dementia, mild cognitive impairment (MCI) and controls and (2) establish whether the ACE-III is useful for diagnosing dementia subtypes. Client records from the Northern Health and Social Care Trust (NHSCT) Memory Service (n = 2,331, 2013–2019) were used in the analysis including people diagnosed with Alzheimer’s disease (n = 637), vascular dementia (n = 252), mixed dementia (n = 490), MCI (n = 920) and controls (n = 32). There were significant differences in total ACE-III and subdomain scores between people with dementia, MCI and controls (p < 0.05 for all), with little overlap between distribution of total ACE-III scores (< 39%) between groups. The distribution of total ACE-III and subdomain scores across all dementias were similar. There were significant differences in scores for attention, memory and fluency between Alzheimer’s disease and mixed dementia, and for visuospatial and language between Alzheimer’s disease–vascular dementia (p < 0.05 for all). However, despite the significant differences across these subdomains, there was a high degree of overlap between these scores (> 73%) and thus the differences are not clinically relevant. The results suggest that ACE-III is a useful tool for discriminating between dementia, MCI and controls, but it is not reliable for discriminating between dementia subtypes. Nonetheless, the ACE-III is still a reliable tool for clinicians that can assist in making a dementia diagnosis in combination with other factors at assessment. Springer Netherlands 2021-09-22 /pmc/articles/PMC8456688/ /pubmed/34566550 http://dx.doi.org/10.1007/s10433-021-00652-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Investigation
Potts, C.
Richardson, J.
Bond, R. B.
Price, R. K.
Mulvenna, M. D.
Zvolsky, P.
Harvey, M.
Hughes, C. F.
Duffy, F.
Reliability of Addenbrooke's Cognitive Examination III in differentiating between dementia, mild cognitive impairment and older adults who have not reported cognitive problems
title Reliability of Addenbrooke's Cognitive Examination III in differentiating between dementia, mild cognitive impairment and older adults who have not reported cognitive problems
title_full Reliability of Addenbrooke's Cognitive Examination III in differentiating between dementia, mild cognitive impairment and older adults who have not reported cognitive problems
title_fullStr Reliability of Addenbrooke's Cognitive Examination III in differentiating between dementia, mild cognitive impairment and older adults who have not reported cognitive problems
title_full_unstemmed Reliability of Addenbrooke's Cognitive Examination III in differentiating between dementia, mild cognitive impairment and older adults who have not reported cognitive problems
title_short Reliability of Addenbrooke's Cognitive Examination III in differentiating between dementia, mild cognitive impairment and older adults who have not reported cognitive problems
title_sort reliability of addenbrooke's cognitive examination iii in differentiating between dementia, mild cognitive impairment and older adults who have not reported cognitive problems
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456688/
https://www.ncbi.nlm.nih.gov/pubmed/34566550
http://dx.doi.org/10.1007/s10433-021-00652-4
work_keys_str_mv AT pottsc reliabilityofaddenbrookescognitiveexaminationiiiindifferentiatingbetweendementiamildcognitiveimpairmentandolderadultswhohavenotreportedcognitiveproblems
AT richardsonj reliabilityofaddenbrookescognitiveexaminationiiiindifferentiatingbetweendementiamildcognitiveimpairmentandolderadultswhohavenotreportedcognitiveproblems
AT bondrb reliabilityofaddenbrookescognitiveexaminationiiiindifferentiatingbetweendementiamildcognitiveimpairmentandolderadultswhohavenotreportedcognitiveproblems
AT pricerk reliabilityofaddenbrookescognitiveexaminationiiiindifferentiatingbetweendementiamildcognitiveimpairmentandolderadultswhohavenotreportedcognitiveproblems
AT mulvennamd reliabilityofaddenbrookescognitiveexaminationiiiindifferentiatingbetweendementiamildcognitiveimpairmentandolderadultswhohavenotreportedcognitiveproblems
AT zvolskyp reliabilityofaddenbrookescognitiveexaminationiiiindifferentiatingbetweendementiamildcognitiveimpairmentandolderadultswhohavenotreportedcognitiveproblems
AT harveym reliabilityofaddenbrookescognitiveexaminationiiiindifferentiatingbetweendementiamildcognitiveimpairmentandolderadultswhohavenotreportedcognitiveproblems
AT hughescf reliabilityofaddenbrookescognitiveexaminationiiiindifferentiatingbetweendementiamildcognitiveimpairmentandolderadultswhohavenotreportedcognitiveproblems
AT duffyf reliabilityofaddenbrookescognitiveexaminationiiiindifferentiatingbetweendementiamildcognitiveimpairmentandolderadultswhohavenotreportedcognitiveproblems